Articles |  |
AAD launches kid-friendly interactive Web site
November 3, 2009 By: Allison Tsai
Schaumburg, Ill. - The American Academy of Dermatology (AAD) is launching an interactive Web site designed to teach kids ages 8-12, and their parents, healthy habits for their skin, hair and nails, according a press release. |
ASDS recognizes Dr. Neil Sadick for excellence in education
November 3, 2009 By: Allison Tsai
Phoenix - The American Society for Dermatologic Surgery (ASDS) presented Neil Sadick, M.D., with the Excellence in Education Award for his "significant commitment time and energy to teach dermatologic surgery and promote the advancement of the specialty," according to Robert Weiss, M.D., president of ASDS. |
Provectus expands compassionate use for PV-10
November 3, 2009 By: Allison Tsai
National report - Provectus Pharmaceuticals has expanded its compassionate use program for PV-10, which is being developed as a therapeutic agent for metastatic melanoma and other cancers, making it available for select cancer patients in the United States, according to a press release. |
Dermatologist wins $101M in Florida's first Powerball
November 3, 2009 By: Allison Tsai
Tallahassee, Fla.- William Steele, M.D., an Orlando dermatologist, is Florida's first Powerball winner, taking a lump sum of $101 million, rather than $189 million spread over 20 years, according to the Bureau News. |
FDA approves Stelara for treatment of psoriasis
October 6, 2009 By: Allison Tsai
Horsham, Pa. ? The U.S. Food and Drug Administration (FDA) has approved the biologic Stelara (ustekinumab, Centocor Ortho Biotech) for the treatment of adult patients with moderate-to-severe plaque psoriasis who are candidates for phototherapy or systemic therapy, according to a Centocor press release. |
Vitamin D may increase chance of melanoma survival
October 6, 2009 By: Allison Tsai
Leeds, England ? Higher levels of Vitamin D are associated with thinner lesions and a lower rate of relapse in melanoma patients, according to a study published in the Journal of Clinical Oncology. |
Melanoma drug breaks new ground
October 6, 2009 By: Allison Tsai
New York ? Scientists are heralding Plexxikon?s experimental melanoma drug as a "breakthrough" after it successfully shrank patients? tumors in a clinical trial, according to onemedplace.com. |
|